中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

慢性HBV感染者肝脏HBV cccDNA含量相关因素分析

陈嵬 吴峰 窦晓光 张琳

引用本文:
Citation:

慢性HBV感染者肝脏HBV cccDNA含量相关因素分析

基金项目: 

国家“十一五”传染病重大专项课题(2008ZX10002-004); 国家自然科学基金项目(30972612); 

详细信息
  • 中图分类号: R512.62

Analysis of related factors for intrahepatic HBV cccDNA level in patients with chronic HBV infection

Research funding: 

 

  • 摘要:

    目的探讨慢性HBV感染者肝组织中HBV cccDNA含量与血清病毒标志物、HBV DNA及肝脏病理分级的关系,为临床评价抗病毒治疗效果及疗程确定提供理论依据。方法以2007年5月-2008年2月住院的30例慢性HBV感染者为研究对象,应用实时荧光定量聚合酶链反应(RT-PCR)方法检测患者肝组织中HBV cccDNA、肝组织总HBV DNA(HBV tDNA)和血清HBVDNA,同时用化学发光免疫分析法检测HBsAg、HBeAg定量,分析感染者肝组织内HBV cccDNA与肝组织内HBV DNA、血清HBVDNA、HBsAg及HBeAg定量水平之间的关系,并比较肝组织中HBV cccDNA含量与肝脏病理炎症和纤维化分级的关系。采用Pear-son简单相关和Spearman等级相关法进行相关性分析。结果 30例慢性HBV感染者肝组织中均可检出HBV cccDNA,范围在3.15×103~1.06×107拷贝/mg;肝组织cccDNA定量与肝组织总HBV DNA定量呈正相关(r=0.375,P<0.05),与血清hbv r="0.174,P">0.05);肝组织中H...

     

  • [1]Locarnini S, Zoulim F.Molecular genetics of HBV infection[J].Antivir Ther, 2010, 15 (13) :3-14.
    [2]Moucari R, Marcellin P.HBsAg seroclearance:prognostic value forthe response to treatment and the long-term outcome[J].Gastroen-terol Clin Biol, 2010, 34 (2) :S119-125.
    [3]Chinese Society of Hepatology and Chinese Society of Infecions Dis-ease, Chinese Medilal Association.The guideline of prevention andtreatment for chronic hepatitis B[J].J Clin Hepatol, 2006, 22 (1) :3-15. (in Chinese) 中华医学会肝病学分会, 中华医学会感染病学会.慢性乙型肝炎防治指南[J].临床肝胆病杂志, 2006, 22 (1) :3-15.
    [4]Quasdorff M, Protzer U.Control of hepatitis B virus at the level of tran-scription[J].J Viral Hepat, 2010, 17 (8) :527-536.
    [5]Danri M, Burda MR, Will H, et al.Increased hepatocyte turnoverand inhibition of woodchuck hepatitis B virus replication by adefovirin vitro do not lead to reduction of the closed circular DNA[J].Hep-atology, 2000, 32 (1) :139-146.
    [6]Delmas J, Schorr O, Jamard C, et al.Inhibitory effect of adefovir onviral DNA synthesis and covalently closed circular DNA formation induck hepatitis B virus-infected hepatocytes in vivo and in vitro[J].Antimicrob Agents Chemother, 2002, 46 (2) :425-433.
    [7]Werle-Lapostolle B, Bowden S, Locarnini S, et al.Persistence ofcccDNA during the natural history of chronic hepatitis B and declineduring adefovir dipivoxil therapy[J].Gastroenterology, 2004, 126 (7) :1750-1758.
    [8]Schultz U, Chisari FV.Recombinant duck interferon gamma inhib-its duck hepatitis B virus replication in primary hepatocytes[J].JVirol, 1999, 73 (4) :3162-3168.
    [9]Liu C, Mu YP, Yang ZG, et al.Clinical significance of monitoringhepatitis B virus Core-related antigens[J].J Clin Hepatol, 2012, 28 (10) :793-796. (in Chinese) 刘成, 慕永平, 杨宗国, 等.乙型肝炎病毒核心相关抗原的监测及临床意义[J].临床肝胆病杂志, 2012, 28 (10) :793-796.
    [10]Yuen MF, Wong DK, Sablon E, et al.HBsAg seroclearance in chronichepatitis B in the Chinese:virological, histological, and clinical as-pects[J].Hepatology, 2004, 39 (6) :1694-1701.
    [11]Zoulim F.New insight on hepatitis B virus persistence from thestudy of intrahepatic viral cccDNA[J].J Hepatol, 2005, 42 (3) :302-308.
    [12]Yuen MF, Wong DK, Fung J, et al.HBsAg seroclearance in chro-nic hepatitis B in Asian patients:replicative level and risk of hepa-tocellular carcinoma[J].Gastroenteroly, 2008, 135 (4) :1192-1199.
    [13]Tuttleman JS, Pourcel C, Summers J.Formation of the pool of co-valently closed circular viral DNA in hepadnavirus-infected cells[J].Cell, 1986, 47 (3) :451-460.
  • 加载中
计量
  • 文章访问数:  2985
  • HTML全文浏览量:  13
  • PDF下载量:  712
  • 被引次数: 0
出版历程
  • 出版日期:  2013-06-20
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回